Open Beta
MetriLume

US marketsNMTC

SEC-sourced researchBeta

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

Company comparison ↗

Data passport

CIK
0001500198
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: September 2024: 3,453,003.0000 USD; September 2025: 9,097,692.0000 USD9.1M USD0 USD0September 2024September 2025
NMTC · Exact amounts and source periods · USD
Period endRevenueFiling date
September 20243,453,003.0000Dec 17, 2025
September 20259,097,692.0000Dec 17, 2025

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
September 20259,097,692.0000-3,605,374.0000-2,837,272.000010,785,647.00003,713,125.0000Dec 17, 2025
September 20243,453,003.0000-12,318,110.0000-11,011,840.00005,369,940.00004,547,927.0000Dec 17, 2025

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$9.1MSeptember 2025Dec 17, 202510-K
Previous period revenueRevenues$3.45MSeptember 2024Dec 17, 202510-K
Net incomeNetIncomeLoss-$3.61MSeptember 2025Dec 17, 202510-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$2.84MSeptember 2025Dec 17, 202510-K
Total assetsAssets$10.79MSeptember 2025Dec 17, 202510-K
Total liabilitiesLiabilities$3.71MSeptember 2025Dec 17, 202510-K

New filings

Explore methodology ↗